Bellevue Asset Management, LLC Gsk PLC Transaction History

Bellevue Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$36.52 - $41.46 $7,304 - $8,292	-200 Reduced 14.65%	1,165 $46,000
Q4 2020 Feb 11, 2021	SELL	$34.07 - $39.94 $4,054 - $4,752	-119 Reduced 8.02%	1,365 $53,000
Q1 2020 May 13, 2020	BUY	$32.47 - $48.83 $3,863 - $5,810	119 Added 8.72%	1,484 $63,000
Q4 2019 Feb 13, 2020	BUY	$42.0 - $48.25 $57,330 - $65,861	1,365 New	1,365 $64,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellevue Asset Management, LLC with notifications on news.